Bioequivalence Studies are a commonly accepted method to demonstrate the therapeutic equivalence between two competing drugs, and form an essential part of the drug registration dossier. Using bioequivalence as a tool to introduce a new generic drug into the market can lead to significant reductions in both the time and costs involved, with the result that the design, performance and evaluation of the related bioequivalence studies have become critical in the drug development process in the pharmaceutical industry. The one day interactive Seminar on Bioequivalence being offered by AIPS will lead to an understanding of the planning, conducting, analyzing and reporting of BE Studies, and will be suitable for professionals in the drug development R&D, regulatory, clinical, medical etc functions.
e-mail : info@aips.ac.in
